⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 1-Aminocyclobutane Carboxylic Acid SCHEMBL972693 | 0.97 | NSD2 (0.48) | — | |
| 1-Aminocyclobutane Carboxylic Acid SCHEMBL14058990 | 0.97 | NSD2 (0.55) | — | |
| Cycloleucine SCHEMBL3164459 | 0.97 | NSD2 (0.48) | — | |
| 1-Aminocyclobutane Carboxylic Acid SCHEMBL4949098 | 0.97 | — | — | |
| Cycloleucine SCHEMBL21462057 | 0.94 | NSD2 (0.50) | — | |
| Cycloleucine SCHEMBL8495 | 0.94 | — | — | |
| SCHEMBL62221 | 0.91 | NSD2 (0.48) | — | |
| SCHEMBL15095885 | 0.91 | NSD2 (0.48) | — | |
| SCHEMBL21423145 | 0.91 | NSD2 (0.48) | — | |
| Cycloleucine SCHEMBL3674853 | 0.91 | NSD2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3792 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745153-A1 | GLP-1, GIP AND GCG RECEPTOR TRIAGONIST AND USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099897-A1 | NOVEL LINKERS AND ITS PREPARATION METHODS THEREOF | ZYDUS LIFESCIENCES LIMITED (IN) | 2026-05-15 | — | — | WO | claimed |
| US-20260116921-A1 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | PROTAGONIST THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12551535-B2 | Peptide pharmaceuticals for insulin resistance | MEDERIS DIABETES, LLC (US) | 2026-02-17 | — | — | US | claimed |
| US-20260035430-A1 | ACYLATED GLUCAGON ANALOGUES | ZEALAND PHARMA AS (DK) | 2026-02-05 | — | — | US | claimed |
| US-20260015393-A1 | NOVEL NMU RECEPTOR 2 AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2026-01-15 | — | — | US | claimed |
| EP-4655311-A1 | METHOD FOR SYNTHESIZING POLYPEPTIDES | Boehringer Ingelheim International GmbH (DE) | 2025-12-03 | — | — | EP | claimed |
| EP-4648849-A1 | NMU RECEPTOR 2 AGONISTS | Boehringer Ingelheim International GmbH (DE) | 2025-11-19 | — | — | EP | claimed |
| US-12473339-B2 | Acylated glucagon analogues | ZEALAND PHARMA A/S (DK) | 2025-11-18 | — | — | US | claimed |
| US-20250304646-A1 | GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS | BOEHRINGER INGELHEIM INT (DE) | 2025-10-02 | — | — | US | claimed |
| EP-0815870-A2 | Composition for prohylaxis or treatment of cerebral infarction | Takeda Chemical Industries, Ltd. (JP) | 1998-01-07 | — | — | EP | claimed |
| EP-0528312-B1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1997-07-16 | — | — | EP | claimed |
| US-5543414-A | VIRICIDES | SYNTEX (USA) INC. (US) | 1996-08-06 | — | — | US | claimed |
| EP-0714909-A1 | Composition for prophylaxis or treatment of pulmonary circulatory diseases | Takeda Chemical Industries, Ltd. (JP) | 1996-06-05 | — | — | EP | claimed |
| EP-0552417-A1 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-28 | — | — | EP | claimed |
| EP-0528312-A2 | Cyclic peptides and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-02-24 | — | — | EP | claimed |
| WO-1993000359-A1 | MODIFIED PEPTIDES TRANSPORTABLE INTO THE CENTRAL NERVOUS SYSTEM | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-01-07 | — | — | WO | claimed |
| US-4833152-A | Anti-hypertensive agents | UNIVERSITY OF MIAMI (US) | 1989-05-23 | — | — | US | claimed |
| EP-0036713-B1 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | UNIVERSITY OF MIAMI (US) | 1984-01-18 | — | — | EP | claimed |
| EP-0036713-A2 | Angiotensin converting enzyme inhibitors | UNIVERSITY OF MIAMI (US) | 1981-09-30 | — | — | EP | claimed |